Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 1;197(7):949-952.
doi: 10.1164/rccm.201707-1446LE.

Endobronchial Optical Coherence Tomography for Low-Risk Microscopic Assessment and Diagnosis of Idiopathic Pulmonary Fibrosis In Vivo

Affiliations

Endobronchial Optical Coherence Tomography for Low-Risk Microscopic Assessment and Diagnosis of Idiopathic Pulmonary Fibrosis In Vivo

Lida P Hariri et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) In vivo endobronchial optical coherence tomography (OCT) accurately identified features of usual interstitial pneumonitis (UIP)/idiopathic pulmonary fibrosis (IPF), including multifocal microscopic honeycombing (HC, arrows) as layered cystic structures embedded within peripheral, destructive fibrosis (f) beyond the bronchiolar epithelium (e). (B) Subsequent surgical lung biopsies were independently diagnosed as UIP, and confirmed the presence of peripheral fibrosis (f) and microscopic honeycombing (arrows). (C) OCT accurately identified traction bronchiectasis (TB) as cystic airway branchpoints, and nondestructive interstitial fibrosis (IF) in alveolar walls in non-UIP/IPF interstitial lung disease (ILD). (D) Subsequent surgical lung biopsy independently confirmed all features visualized on OCT, including traction bronchiectasis (TB, right inset) and interstitial fibrosis (IF) in alveolar walls (left inset). No honeycombing or other UIP features were seen, and the biopsy was diagnosed as a non-UIP/IPF ILD.
Figure 2.
Figure 2.
(A) In vivo endobronchial optical coherence tomography (OCT) identified microscopic honeycombing (HC) and destructive peripheral fibrosis (f) in a patient with nondiagnostic high-resolution computed tomography and indeterminate lung biopsy. A branching bronchiole (B) is also visible. (B) OCT visualized spatial heterogeneity as regions of preserved alveoli (a) adjacent to fibrosis.

Comment in

Similar articles

Cited by

References

    1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824. - PMC - PubMed
    1. Raghu G, Anstrom KJ, King TE, Jr, Lasky JA, Martinez FJ Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366:1968–1977. - PMC - PubMed
    1. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–2082. - PubMed
    1. King TE, Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083–2092. - PubMed
    1. Gotway MB, Freemer MM, King TE., Jr Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias. Thorax. 2007;62:546–553. - PMC - PubMed

Publication types

LinkOut - more resources